Skip to content

Clinical Pharmacy Congress 2026

Medicines are becoming more complex, while the systems that deliver them are under increasing pressure. For pharmacy teams, the challenge is not only optimisation, but how therapies are initiated, supplied and supported in practice.

Sciensus works in partnership with the NHS to deliver clinical in-home care and digitally enabled pathways that reduce delays, improve coordination and support safer, more consistent treatment.

At Clinical Pharmacy Congress, we are sharing how connected approaches to medicines delivery can help pharmacy teams improve outcomes while making better use of NHS capacity.

  • Deliver complex medicines safely beyond the hospital
  • Streamline prescribing, dispensing and delivery pathways
  • Reduce operational burden on pharmacy teams
  • Improve continuity and patient experience
  • Generate meaningful real-world insight through routine care

Meet the Sciensus team

to explore how clinical in-home care can support pharmacy-led pathways. Visit us at F40.

Andrea Roberts

Director of NHS Services & Operational Interface

Gurbir Johal

Clinical Business Partner

Debbie Goodwin

Head of NHS Service Development

Nicky Gray

NHS Services Director

Victoria Deadman

NHS Services Director

Digital. Timely. Scalable. Connected.

Clinical in-home care is more than a delivery model. It is infrastructure that enables medicines to be initiated and managed efficiently at scale.
Through integrated digital systems and coordinated service delivery, Sciensus supports:

  • Faster progression from prescription to treatment
  • Reduced duplication and manual processes
  • Greater visibility across the patient pathway
  • More responsive and connected care

Faster pathways. Lower risk. Driving smarter use of NHS resources

Delays in treatment initiation and fragmented processes create risk for both patients and services. Pharmacy teams play a critical role in managing these pressures.
Sciensus supports more streamlined pathways that reduce friction across referral, prescribing and supply, enabling earlier treatment initiation and more consistent delivery.
This allows pharmacy teams to focus on clinical decision-making rather than operational complexity.

Supporting medicines optimisation in practice

Clinical in-home care aligns closely with NHS priorities and the evolving role of pharmacy within the system.

  • Care closer to home
  • Digital pathways over manual processes
  • Reduced pressure on hospital services
  • Improved adherence and continuity
  • Better use of clinical pharmacy expertise

These models support a more sustainable approach to medicines optimisation, particularly for complex and high-cost therapies.

Real-world insight, built into delivery

As expectations around real-world evidence increase, pharmacy teams are increasingly central to data generation and service evaluation.
Clinical in-home care enables structured insight capture through routine interactions, providing:

  • Better visibility of adherence and persistence
  • Understanding of patient experience and barriers
  • Insight into service utilisation and pathway efficiency

This creates a more complete picture of how therapies perform in practice, supporting ongoing optimisation and value demonstration.

Let’s continue the conversation

If you are attending Clinical Pharmacy Congress, join our session or visit us at Stand F40 to discuss how these approaches could support your services.

Alternatively, get in touch to continue the conversation with our team.

Digital homecare innovation: Reducing inequality, optimising medicine pathways and improving outcomes across clinical pharmacy.

Date: 8 May 2026

Time: 10:45 – 11:30

Technology & Innovation Theatre

This session highlights how digital homecare technology streamlines prescribing, reduces NHS workload, and improves equity and patient outcomes. It shows how real time visibility, digital onboarding, and adherence to boosting tools enhance clinical pharmacy efficiency while supporting faster access to treatment and more sustainable medicines pathways across the NHS.

Expertise that makes the difference

Leveraging over 30 years of clinical experience, deep therapeutic expertise and personalised digital innovation, we help biopharma, CROs and CCOs bring treatments to patients across Europe faster.

0

Years’ experience in Europe

0

patients supported each year

0

patient interactions

0

patients active on our apps

Get a faster route into Europe

Request a meeting for a focused strategic conversation on your asset, where we’ll explore how you can accelerate access to Europe by using one integrated partner for end-to-end support.

This field is for validation purposes and should be left unchanged.